<DOC>
	<DOCNO>NCT00596297</DOCNO>
	<brief_summary>The purpose study determine whether preoperative intravitreal bevacizumab effective reduce intra-operative postoperative bleeding diabetic patient submit par plana vitrectomy vitreous hemorrhage .</brief_summary>
	<brief_title>Preoperative Bevacizumab Vitreous Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Hemorrhage</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Diabetic retinopathy cause significant vitreous hemorrhage visual acuity loss last three month patient previously treat four month previously LASER treat . Previous intraocular surgery cataract surgery Retinal detachment Use anticoagulants drug aspirin Vitreous hemorrhage clearance week3 study period History previous thromboembolic event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Vitreous Hemorrhage</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>par plana vitrectomy</keyword>
	<keyword>preoperative</keyword>
</DOC>